Showing results (61-70 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Radon and lung cancerTarsheen K Sethi, Moataz N El-Ghamry, Goetz H KloeckerClinical Advances in Hematology & Oncology : H&O|August 2, 2018
Bromodomain inhibitors: what does the future hold?Seemana Bhattacharya, Sujan Piya, Gautam BorthakurClinical Advances in Hematology & Oncology : H&O|October 21, 2005
Resetting the immune system in immune thrombocytopenic purpura: immunoablative strategiesPatrick F Fogarty, Cynthia E DunbarClinical Advances in Hematology & Oncology : H&O|November 1, 2005
Evolving role of irinotecan in small-cell lung cancerDavid R Spigel, F Anthony GrecoClinical Advances in Hematology & Oncology : H&O|November 1, 2005
Current treatment recommendations for stage III non-small-cell lung carcinomaMarie P Davis, William T SauseClinical Advances in Hematology & Oncology : H&O|November 1, 2005
Clotting mechanisms and cancer: implications in thrombus formation and tumor progressionAnna Falanga, Marina Marchetti, Alfonso Vignoli, et al.Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
Optimizing the management of chemotherapy-induced neutropeniaDavid C DaleClinical Advances in Hematology & Oncology : H&O|November 1, 2005
The role of prophylactic cranial radiation in the treatment of non-small-cell lung cancerJanessa J Laskin, Alan B SandlerClinical Advances in Hematology & Oncology : H&O|November 1, 2005
Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioningFrédéric Baron, Rainer StorbClinical Advances in Hematology & Oncology : H&O|January 16, 2010
VEGF inhibitors in brain tumorsPriscilla K Brastianos, Tracy T BatchelorPageof 68